Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-21-072553
Filing Date
2021-05-27
Accepted
2021-05-26 18:14:08
Documents
37

Document Format Files

Seq Description Document Type Size
1 S-1 tm2111636-5_s1.htm S-1 2008692
2 EXHIBIT 1.1 tm2111636d6_ex1-1.htm EX-1.1 388523
3 EXHIBIT 2.1 tm2111636d3_ex2-1.htm EX-2.1 5499
4 EXHIBIT 3.1 tm2111636d3_ex3-1.htm EX-3.1 11732
5 EXHIBIT 3.2 tm2111636d3_ex3-2.htm EX-3.2 34524
6 EXHIBIT 3.3 tm2111636d3_ex3-3.htm EX-3.3 157048
7 EXHIBIT 4.1 tm2111636d6_ex4-1.htm EX-4.1 4389
8 EXHIBIT 5.1 tm2111636d6_ex5-1.htm EX-5.1 10155
9 EXHIBIT 10.1 tm2111636d3_ex10-1.htm EX-10.1 77581
10 EXHIBIT 10.2 tm2111636d3_ex10-2.htm EX-10.2 125383
11 EXHIBIT 10.3 tm2111636d3_ex10-3.htm EX-10.3 76302
12 EXHIBIT 10.4 tm2111636d6_ex10-4.htm EX-10.4 80819
13 EXHIBIT 10.5 tm2111636d3_ex10-5.htm EX-10.5 66228
14 EXHIBIT 10.6 tm2111636d6_ex10-6.htm EX-10.6 91281
15 EXHIBIT 10.7 tm2111636d6_ex10-7.htm EX-10.7 88958
16 EXHIBIT 10.8 tm2111636d6_ex10-8.htm EX-10.8 89226
17 EXHIBIT 10.9 tm2111636d6_ex10-9.htm EX-10.9 138118
18 EXHIBIT 10.10 tm2111636d3_ex10-10.htm EX-10.10 290251
19 EXHIBIT 10.11 tm2111636d6_ex10-11.htm EX-10.11 238830
20 EXHIBIT 23.1 tm2111636d3_ex23-1.htm EX-23.1 2167
21 EXHIBIT 99.1 tm2111636d3_ex99-1.htm EX-99.1 2791
22 EXHIBIT 99.2 tm2111636d3_ex99-2.htm EX-99.2 2958
23 EXHIBIT 99.3 tm2111636d3_ex99-3.htm EX-99.3 2753
24 EXHIBIT 99.4 tm2111636d3_ex99-4.htm EX-99.4 2782
25 GRAPHIC lg_acurxpharma-4c.jpg GRAPHIC 20442
26 GRAPHIC tm2111636d2-tbl_activ4c.jpg GRAPHIC 94481
27 GRAPHIC tm2111636d1-tbl_mecha4clr.jpg GRAPHIC 114251
28 GRAPHIC tm2111636d1-bc_chlora4clr.jpg GRAPHIC 65646
29 GRAPHIC tm2111636d1-lc_animal4clr.jpg GRAPHIC 199105
30 GRAPHIC tm2111636d1-lc_syrian4clr.jpg GRAPHIC 131934
31 GRAPHIC tm2111636d1-tbl_clinic4clr.jpg GRAPHIC 86273
32 GRAPHIC tm2111636d1-bc_ibezapo4clr.jpg GRAPHIC 111317
33 GRAPHIC tm2111636d2-tbl_compe4c.jpg GRAPHIC 170390
34 GRAPHIC tm2111636d1-ph_produc4clr.jpg GRAPHIC 119470
35 GRAPHIC tm2111636d6_ex5-1img01.jpg GRAPHIC 2277
36 GRAPHIC tm2111636d6_ex4-1img001.jpg GRAPHIC 941070
37 GRAPHIC tm2111636d6_ex4-1img002.jpg GRAPHIC 657405
  Complete submission text file 0001104659-21-072553.txt   7737395
Mailing Address 22 CAMELOT COURT WHITE PLAINS NY 10603
Business Address 22 CAMELOT COURT WHITE PLAINS NY 10603 914-949-3898
Acurx Pharmaceuticals, LLC (Filer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-256516 | Film No.: 21967758
SIC: 2834 Pharmaceutical Preparations